David L. Stern

The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar.

California Cryobank LLC provides donor sperm, private semen cryopreservation and reproductive services. The firm provides donor matching consultation, genetic counseling, family planning, vial buy-back and exchange, and directed donor services. The company was founded by Charles A. Sims and Cappy M. Rothman in 1977 and is headquartered in Los Angeles, CA.

Boston IVF, Inc. operates fertility clinics which offer reproductive technologies. The firm's services include IVF laboratory, consultations and evaluations, blood/ultrasound cycle monitoring, Semen analysis, IUI, hysterosalpingogram, Saline Infused Sonogram, patient education, Domar center for mind/body health and acupuncture. The company was founded by Merle Berger and Michael Alper in 1986 and is headquartered in Waltham, MA.

Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.

Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ.

OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA.